20
Apitoria Pharma Private Limited Hyderabad In, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their significant offerings is Fluoxetine hydrochloride, Process II, supported by a 'Valid' Certificate of Suitability (CEP) with the number CEP 2019-226 - Rev 03
This Chemical Type CEP, issued on November 16, 2023, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 1104 associated with this CEP further emphasizes